Poorer cognitive trajectories seen for Hispanics\/Latinos with central obesity in presence of cardiometabolic abnormalities<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Aug. 3, 2021 (HealthDay News) — For Hispanics\/Latinos, central obesity in the presence of cardiometabolic abnormality is associated with poorer cognitive trajectories, according to a study recently published in the Journal of Alzheimer’s Disease<\/em>.<\/p>\n Ariana M. Stickel, Ph.D., from the University of California in San Diego, and colleagues examined central obesity, cognitive aging, and the role of concomitant cardiometabolic abnormalities in a cohort of 6,377 diverse Hispanics\/Latinos enrolled in two cohorts. Participants were aged 45 years and older at the first cognitive testing visit and underwent assessment for cognitive outcomes at a second visit an average of seven years later.<\/p>\n The researchers found that after adjustment for covariates, central obesity was mainly not associated with cognitive outcomes. In the Study of Latinos-Investigation for Neurocognitive Aging, cardiometabolic abnormality was linked to poorer cognitive function and to more pronounced cognitive declines over seven years among individuals with central obesity; this finding was consistent across cognitive domains.<\/p>\n “These data clearly suggest that individuals with obesity take a big hit to their cognition when other risk factors, such as diabetes and high cholesterol, are present,” Stickel said in a statement. “Obesity\/fat stigma tends to put a hyper-focus on a number on the scale, sometimes at the expense of other health goals. If maintaining a specific weight is difficult, preventing or managing cardiometabolic abnormalities is just as important, if not more important from a cognitive health standpoint.”<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n